HIPAA.com Launches HIPAA TV(e of unsecured protected health informat...),Health
Navigation Links
HIPAA.com Launches HIPAA TV
Date:9/15/2009
e of unsecured protected health information to unauthorized persons, and financial incentives for healthcare providers to adopt and meaningfully use electronic health records, all of which were enacted as part of the American Recovery and Reinvestment Act in February 2009; and practical guidance on how to comply with HIPAA and HITECH Act rules, written not as legal advice, but as a roadmap of what to do and how to go about it.
For more information visit www.HIPAA.com and www.HIPAA.tv
'/>"/>
| SOURCE HIPPA.com Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Veterinarian Group Launches New Website to Help Pet Owners With Medical Advice and the Best Vet-Approved Products
2. Senior Living Residences Launches Innovative Nutrition Program to Promote Cognitive Health and Lower the Risk of Alzheimers Disease
3. Sage Products Launches Comprehensive Wellness Program with EngagementHealth(R)
4. Cooperative of American Physicians, Inc. Launches CAP Cares
5. DaVita Launches Nationwide Series of Kidney Awareness Run/Walks
6. Bupa Launches its 2009 International Charity Challenge to Help a Rural Community in Ecuador
7. Solta Medical Launches illumiNATION tour in U.S. and Europe to Introduce New Thermage CPT(TM) and Fraxel re:store(R) Dual Systems
8. Prime Retail Launches Operation Shop Pink
9. NIAID launches 2009 H1N1 influenza vaccine trial in pregnant women
10. Prentice Womens Hospital Launches New Initiative to Better Identify and Address Postpartum Depression
11. CONCERTA(R) (methylphenidate HCl) LAUNCHES MOBILE WEB EXPERIENCE TO PROVIDE TOOLS AND SUPPORT FOR ADHD AWARENESS
Post Your Comments:
(Date:11/25/2009).../PRNewswire-USNewswire/--TheBlackAIDSInstituterece...veleadershipfor2010. ,, ThenewBoardMembersareah...olicy,law,finance,governmenthealthprograms,editori...omawiderangeofpersonalbackgroundsincludingbothhete...emselves,andrepresentingmultipleagegroups. ,, (...
(Date:11/25/2009)...dorsements,Business,andPressJoinEfforttoEducate ,...Onceagain,theNationalBipolarFoundationandtheMedicA...afe,tilStable"program,whichisnowbeingwidelyaccepte...Today,theNationalBipolarFoundationreceivedaproclam...mtheLt.GovernorofLouisianaMitchLandrieu.TheNationa...
(Date:11/25/2009)...evidence of a statistically significant survival b...e estrogen receptor (ER)-positive tumors had high ...18 (ER-alpha S118-P), according to a brief communi...l of the National Cancer Institute . , Approxima...oxifen. Preclinical studies have shown that ER-alp...
(Date:11/25/2009)...ood pressure? This simple question has been the f...ss-related gene Modulates High Blood Pressure in M...This simple question has been the focus of intense...r the first time established a link between a nove... to stress in mice as well as humans. The studies ...
(Date:11/25/2009)...o fight rheumatoid arthritis, could help newly dia...DAY, Nov. 25 (HealthDay News) -- A drug commonly u... arthritis now also shows some promise in helping ..., The drug, rituximab (Rituxan), helped patients k...gh the disease had destroyed some of their pancrea...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3[0] Black AIDS Institute Announces 2010 Board Election Results[0] First Time-Door is Open for Family Discussion of Bipolar Disorder[1] News brief: Estrogen receptor-alpha, breast cancer patients and tamoxifen response[0] New stress-related gene modulates high blood pressure in mice and men[1] Type 1 Diabetes May Have a New Foe
...re Holdings,Inc. (Amex: PRZ ), one of the nation,...rgical solutions and services, today announced tha...PSHS Alpha Partners, Ltd., which,owns and operates...es have provided for the release of approximately ...
...ce Patient Safety, Improve Efficiency, SAN RAMON,...lobal services firm that specializes in enabling,t...tions, today announced,that it has been awarded a ... install clinical components of its Keane,InSight ...
...idan and Others Join Carlos Santana to ...BOCA RATON, Fla., Sept. 5 Spirit of Women Health,...unce today the opening of,bidding for the Spirit o...ing the National Stroke Association and,Peripheral...
...nvulsants, Especially When Prescribed,Off-Label, ... effective in treating bipolar disorder, fibromyal...scribed drugs are not always the best,initial choi...lic information project of Consumers Union., The ...
...tech,Incorporated (Nasdaq: MTEX ), a leading deve... care solutions, today announced a new sales tools...nt sales force of more,than 569,000 independent As... the company,s largest annual gatherings of,sales ...
...ders to Bicycle a Combined 3,000 Miles in Two Wee...Health and Hope, PHILADELPHIA, Sept. 5 It,s poss...rage, live less healthy and possibly,even shorter ...aths and affect the quality of life of more than 9...
Other Medicine News:Health News:PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers 2Health News:PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers 3Health News:PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers 4Health News:Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility 2Health News:Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility 3Health News:Online Celebrity Shoe Charity Auction for Women's Heart Health Opens Bidding 2Health News:Online Celebrity Shoe Charity Auction for Women's Heart Health Opens Bidding 3Health News:Consumer Reports' Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best 2Health News:Consumer Reports' Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best 3Health News:Mannatech Launches Phase One of New Sales and Training Tools 2Health News:Mannatech Launches Phase One of New Sales and Training Tools 3Health News:CIGNA Employees Take to the Road to Promote Health and Wellness 2Health News:CIGNA Employees Take to the Road to Promote Health and Wellness 3Health News:CIGNA Employees Take to the Road to Promote Health and Wellness 4PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery CentersKeane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care FacilityOnline Celebrity Shoe Charity Auction for Women's Heart Health Opens BiddingConsumer Reports' Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always BestMannatech Launches Phase One of New Sales and Training ToolsCIGNA Employees Take to the Road to Promote Health and Wellness
(Date:11/25/2009)...if.,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announ...sPROTECT-1(theProspectiveRandomizedOralTherapyEval...82-B)inpatientswithmoderate-to-severeCrohn,sdiseas...ndtolerabilityprofile.Thestudydemonstratedevidence...sdefinedasa70-pointdecreaseintheCrohn,sDiseaseActi...
(Date:11/24/2009)...4/PRNewswire/-- ,, WHAT:RomHoubens,aBelgianmant...ident,wasactuallyfullyconsciousandawakeduringthatt...eDynaVoxEyeMaxwasfeaturedinthesegmenttoillustrateh...unlockcommunication. ,, WHEN:GoodMorningAmerica...avoxtech.com ,, WHO:RomHoubenswasanengineer...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--QuestDiagnosticsIncorpo...ostictesting,informationandservices,announcedthati...thcareConferenceinNewYorkCity.Thepresentationissch...Time. ,, Duringtheconference,thecompanywillreaf...,operatingincometoexceed18%ofrevenues,anddilutedea...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Stereotactic Radiosurgery As Effective in Eliminating Parkinsons Disease Tremors As Other Treatments But Less Invasive 60570 1Stereotactic Radiosurgery As Effective in Eliminating Parkinsons Disease Tremors As Other Treatments But Less Invasive 60570 2Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and 26quot 3BArthritis Kits 26quot 3B 5937 1Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and 26quot 3BArthritis Kits 26quot 3B 5937 2Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutritional Supplies and 26quot 3BArthritis Kits 26quot 3B 5937 3STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 1STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 2STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 3STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 4STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 5STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 6STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 7STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 8STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 9STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 10STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 11STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 12STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 13STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 14STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 15STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 16STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 17STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 18STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 19STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 20STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 21STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 22STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 23STAAR Surgical Generates 24464 000 in Cash from Operations During Third Quarter 5935 24[0] ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference[0] DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years[0] Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference
...ented at ASCO Annual Meeting -, SOUTH SAN FRANCIS...ll/,-- Poniard Pharmaceuticals, Inc. (Nasdaq: PAR...gy, today announced safety and efficacy results,fr... of picoplatin and,liposomal doxorubicin in patien...ancer. Results demonstrated signals of clinical ac...
...cal Phase 2 data presented at American Society of ...eting, PRINCETON, N.J., June 1 Medarex, Inc.,(Na...llow-up and overall,survival (OS) results from a P...ilimumab in combination with dacarbazine (DTIC) wh...t or greater than 4 years of follow-up. This,inclu...
Other Medicine Technology:Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 2Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 3Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 4Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 5Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 2Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 3Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |